Express News | Praxis Precision Medicines Shares Are Trading Higher After Guggenheim Initiated Coverage With a Buy Rating and a $155 Price Target

BenzingaJun 18 09:56 ET

Express News | Praxis Precision Medicines Inc : Guggenheim Initiates Coverage With Buy Rating; Target Price $155

ReutersJun 18 07:52 ET

Praxis Precision Med Initiated at Buy by Guggenheim

Praxis Precision Med Initiated at Buy by Guggenheim

Dow JonesJun 18 06:48 ET

Guggenheim Initiates Praxis Precision Medicines(PRAX.US) With Buy Rating, Announces Target Price $155

Guggenheim analyst Yatin Suneja initiates coverage on $Praxis Precision Medicines(PRAX.US)$ with a buy rating, and sets the target price at $155.According to TipRanks data, the analyst has a success r

moomoo NewsJun 18 06:31 ET · Ratings

Piper Sandler Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $270

Piper Sandler analyst Yasmeen Rahimi maintains $Praxis Precision Medicines(PRAX.US)$ with a buy rating, and maintains the target price at $270.According to TipRanks data, the analyst has a success rat

moomoo NewsJun 17 06:31 ET · Ratings

Truist Financial Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating

Truist Financial analyst Joon Lee maintains $Praxis Precision Medicines(PRAX.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 48.3% and a total average return of 23

moomoo NewsJun 13 07:32 ET · Ratings